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Recent studies show that higher order oscillatory interactions such as cross-frequency coupling are
important for brain functions that are impaired in schizophrenia, including perception, attention and
memory. Here we investigated the dynamics of oscillatory coupling in the hippocampus of awake rats upon
NMDA receptor blockade by ketamine, a pharmacological model of schizophrenia. Ketamine (25, 50 and
75 mg/kg i.p.) increased gamma and high-frequency oscillations (HFO) in all depths of the CA1-dentate
axis, while theta power changes depended on anatomical location and were independent of a transient
increase of delta oscillations. Phase coherence of gamma and HFO increased across hippocampal layers.
Phase-amplitude coupling between theta and fast oscillations was markedly altered in a dose-dependent
manner: ketamine increased hippocampal theta-HFO coupling at all doses, while theta-gamma coupling
increased at the lowest dose and was disrupted at the highest dose. Our results demonstrate that ketamine
alters network interactions that underlie cognitively relevant theta-gamma coupling.
O
scillations in the activity of neuronal populations are associated with the coordination of distributed
neuronal groups believed to underlie cognitive processing1–3. Disturbance in cortical oscillations has
been suggested as a possible neural basis for symptoms of mental disorders such as schizophrenia4,5. In
particular, aberrant gamma-frequency oscillations (30–100 Hz) have been reported in schizophrenic patients6,7,
but alterations in other frequency bands are also likely to play a role8.
Acute blockade of glutamate N-methyl-D-aspartate receptors (NMDAR) by ketamine in humans induces
negative and positive symptoms similar to those found in schizophrenia9, and exacerbates its core symptoms
when administered to patients10. In animals, acute NMDAR blockade induces behavioural, biochemical and
electrophysiological alterations11–15 that present predictive, constructive and face validity as a pharmacological
model for schizophrenia16. Previous studies in rodents have shown that ketamine increases the power of
gamma12,15 and delta17 oscillations, andmay differentially affect theta power depending on recording region15,18,19.
Of note, some of the electrophysiological alterations induced by ketamine, such as aberrant gamma oscillations,
have been dissociated from its motor effects14.
Brain rhythms of different frequencies are not independent, but can rather interact in several ways20. Cross-
frequency coupling (CFC) among neuronal oscillations has been linked to brain functions such as detection of
sensory signals, reward signalling, decision-making, working memory, attention and learning (see ref. 21 for a
review). CFC patterns differ across brain areas22,23 and change dynamically in a task-relevant manner in response
to sensory, motor and cognitive events21,24. Although CFC has been implied in several brain functions, few studies
have attempted to characterize CFC in schizophrenia25 or in its animal models13.
In this work we investigated the effects of acute NMDAR blockade by ketamine on the dynamics of spectral
content and oscillatory interactions in the hippocampus, a brain region that has long been associated with the
schizophrenia phenotype26. We focused on cognitively relevant frequency bands: theta (5–10 Hz), gamma (30–
100 Hz) and high-frequency oscillations (HFO; 110–160 Hz). We found that ketamine leads to frequency- and
region-specific alterations of local field potential (LFP) power, altered phase synchrony, and aberrant cross-
frequency coupling of neural oscillations. Taken together, these results demonstrate that ketamine distorts
normal oscillatory interactions in the rat hippocampus.
Results
NMDAR blockade increases locomotion and high frequency oscillations. Consistent with previous reports11,12,14,
we found that systemic administration of ketamine increased locomotor activity (Fig. 1a, b) and gamma power
(Fig. 2) at all doses studied. While peak locomotion speed was similar for all doses (Fig. 1c), higher ketamine doses
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were associated with greater latency to peak locomotor activity (16, 36
and 76 minutes, respectively; Fig. 1d), mainly due to transitory ataxia.
In Fig. 2a we show the gamma band power averaged across all
electrodes in a representative animal treated with ketamine. Peak
gamma power occurred during the first hour post-ketamine injec-
tion, and approached baseline levels three hours afterwards. In
Fig. 2b we show the time-course of gamma power variations in each
of the 8 electrodes in the same animal (Fig. 2b inset); notice that
gamma power increases along the CA1-dentate gyrus axis, as prev-
iously reported27. The increase in gammapower induced by ketamine
was apparent in all recording sites; in fact, baseline normalised
gamma power provided similar time-courses for all electrodes in
the bundle (data not shown). At the group level, in contrast to the
time-course of locomotor activity (Fig. 1a), gamma power peaked
within 5–10 minutes after ketamine injection at all doses studied
(Fig. 2c). These results show that the time-course of locomotor and
electrophysiological alterations caused by NMDAR blockade may be
dissociated (see cross-correlations in Fig. 2c insets and ref. 14).
We found that ketamine also increased hippocampal HFO power,
with a similar time-course to the increase in gamma oscillations (see
Fig. 3a for a representative electrode and Fig. 3b for group results).
Incidentally, it has recently been shown that ketamine increases HFO
activity in motor cortex, nucleus accumbens, and other basal ganglia
nuclei28,29, suggesting that abnormally high levels of HFO may be a
widespread effect of NMDAR blockade.
NMDAR blockade modulates hippocampal theta oscillations in a
layer-dependent manner. Along with high-frequency alterations, we
found that low-frequency LFP signals were also modulated by
NMDAR blockade. In Fig. 4a we show the power spectral density
in the theta range of three electrodes recorded simultaneously from an
animal during pre- and post-injection of 50 mg/kg ketamine IP.
Notice in this example that while theta band power decreased after
ketamine injection in stratum pyramidale, it did not change in
stratum radiatum, and was markedly increased at the hippocampal
fissure. Notice further that theta peak frequency was shifted in all
recording sites from 6–8 Hz during drug-free locomotion periods
to 7–10 Hz following ketamine injection, probably due to increases
in locomotion speed. Fig. 4b shows group results for theta band power
modulation during peak locomotion induced byNMDAR blockade in
a subset of electrodes located in stratum oriens-alveus and pyrami-
dale (Electrodes #1–3) and in another subset located in stratum
lacunosum-moleculare, hippocampal fissure and dentate gyrus
(Electrodes #6–8). The mean power spectral density is displayed in
Supplementary Fig. S1 online. Ketamine differentially affected theta
band power in the two subsets of electrodes at all doses studied, and
this effect occurred specifically during hyperlocomotion (Fig. 4c).
A recent study showed that ketamine IP at the dose of 50 mg/kg –
but not 20 mg/kg – increases the power of hippocampal delta
(1–4 Hz) oscillations during a period of ,15 minutes following
the injection17 (see also ref. 19). Since a greater level of delta power
can potentially lead to a greater area under the curve of the power
spectral density in the theta range (spectral leakage30) even in the
absence of a theta peak, we next investigated whether putative
changes in delta power could account for the changes in theta power
reported above. As shown in Fig. 4d, delta power was highly modu-
lated by locomotion speed; in particular, delta power was high during
periods of low locomotion preceding saline and ketamine injections,
and also after the hyperlocomotion episode had ceased (Fig. 4d).
Thus, the apparent high levels of theta band power in these periods
(Fig. 4c) are actually due to spectral leakage from delta power and do
not correspond to a genuine theta activity. Consistent with a previous
report17, the doses of 50 and 75 mg/kg transiently increased delta
power, which returned to basal levels before the peak of ketamine-
induced hyperlocomotion activity (Fig. 4d), i.e., when the layer-
dependent variations in theta power were most striking (Fig. 4c).
Moreover, contrary to theta, delta power time-course was qualita-
tively similar in all electrodes (Fig. 4d). Therefore, ketamine-induced
alterations in delta power cannot account for the dichotomy in theta
modulation across the CA1-dentate gyrus axis observed during
hyperlocomotion.
NMDAR blockade leads to increased phase synchrony in multiple
high-frequency bands. We next investigated the levels of phase
coherence across recording sites, and found that ketamine induced
transient hypersynchrony in a wide range of fast LFP oscillations
from 30 to 200 Hz (Fig. 5a). Phase coherence spectra were
typically multimodal, exhibiting peak values in the traditional
gamma range, as well as in frequencies above 100 Hz. The changes
in coherence induced by ketamine were observed among electrode
pairs located in multiple hippocampal depths (Fig. 5a). Interestingly,
electrode pairs located at stratum lacunosum-moleculare and dentate
gyrus presented coherence peaks in a faster gamma frequency than
electrode pairs located at stratum oriens-alveus and pyramidale.
Peaks in HFO phase coherence were particularly prominent for
electrodes pairs across hippocampal layers.
In Fig. 5b we show time-courses of mean phase coherence changes
in the gamma and HFO bands across all electrode pairs. Gamma
and HFO phase coherence increased immediately after ketamine
injection and only returned to baseline values after the hyperlocomo-
tion episode ended. Interestingly, the relative increase in phase coher-
ence induced by ketamine was much more prominent for HFO than
gamma oscillations. In all, these results show that ketamine alters
inter-site synchrony of multiple frequency bands in the hippocampus.
NMDAR blockade alters cross-frequency coupling. We next
examined the effects of ketamine on the coupling between low- and
Figure 1 | Acute injection of sub-anaesthetic doses of ketamine induces
hyperlocomotion in rodents. (a) Freely moving rats received intraperitoneal
(IP) injections of saline and ketamine (25 mg/kg – n 5 6; 50 mg/kg – n 5 7;
75 mg/kg – n 5 5) at 60 and 120 min after the beginning of the recording
session, respectively, and were monitored for additional 180 min. In this
and all other figures, grey and black arrows denote saline and ketamine
injections, respectively. Locomotion speed was monitored at 30 frames per
second and averaged over 5-min blocks among all animals from each group.
Notice that ketamine induces an increase in locomotion speed at all doses.
(b–d) Total locomotion (b), peak speed (c), and latency to peak locomotion
speed (d) after ketamine injection are shown for each dose. Data are shown
as mean 6 SEM over animals.
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high-frequency LFP oscillations. Typically, low frequency phase
modulates the amplitude of higher frequency oscillations22. This
type of oscillaory interaction is deemed to be involved in cognitive
processing (see ref. 21 for a review). Consistent with previous
reports23,24,31, we found prominent CFC in most CA1 electrodes;
theta phase strongly modulated the amplitude of HFO in electrodes
located above the pyramidal layer (i.e., stratum oriens-alveus), while
the amplitude modulation of high-gamma (HG; 60–100 Hz) was
maximal in electrodes located in stratum lacunosum-moleculare
and hippocampal fissure23. Finally, in spite of the low-gamma (30–
60 Hz) power increase depicted in Fig. 2a, we did not find prominent
coupling between theta and low-gamma in CA1, as reported
previously23.
To illustrate the effect of acuteNMDARblockade onCFC, for each
example in Fig. 6 we show six comodulation maps computed for 5-
min time blocks before and after ketamine injection (as indicated by
20 40 60 80 100
0
1
2
3
4
5 x 10
-4
Frequency (Hz)
 
Basal (0−60 min)
Saline (60−120 min)
Ketamine (120−180 min)
Ketamine (180−240 min)
Ketamine (240−300 min)
0 60 120 180 240 300
0
1
2
3
4
5
6
Time (minutes)
 
1
2
3
4
5
6
7
8
E
le
ct
ro
de
 #
M
ea
n 
ga
m
m
a 
po
w
er
 (m
V
2 /
H
z)
x 10
-4
P
ow
er
 (m
V
2 /
H
z)
a b
c
Basal Saline
Ketamine (IP)
0-60’
0
1
2
3
4
0
1
2
3
4
M
ea
n 
no
rm
al
is
ed
 g
am
m
a 
po
w
er
0
1
2
3
4
60-120’ 120-180’
Basal Saline
Ketamine (IP)
0-60’ 60-120’ 120-180’
Basal Saline
Ketamine (IP)
0-60’ 60-120’ 120-180’
*
*
*
0 60 120 180 240 300
0
2
4
6
Ketamine 25 mg/kg IP
0 60 120 180 240 300
0
2
4
6
N
or
m
al
is
ed
 g
am
m
a 
po
w
er
 (r
at
io
 to
 b
as
al
)
Ketamine 50 mg/kg IP
0 60 120 180 240 300
0
2
4
6
Time (minutes)
Ketamine 75 mg/kg IP
Locomotion
Gamma
-100 0 100
0
0.5
1
CC
G
Lag (minutes)
-100 0 100
0
0.5
1
CC
G
Lag (minutes)
-100 0 100
0
0.5
1
CC
G
Lag (minutes)
Figure 2 | Ketamine-induced increase in gamma power can be temporally dissociated from its effect on locomotor activity. (a) Representative power
spectra in an animal treated with 50 mg/kg ketamine IP (mean over all 8 electrodes; 5-Hz moving average smoothing). (b) Time-course of mean gamma
power (30–100 Hz) for all electrodes in the same animal as in (a). Inset shows histology with estimated electrode depths (indicated by green dots at the
right of the lesion). Grey and black arrows denote saline and ketamine injections, respectively. (c) Left: Group results of normalised gamma power
variations (blue) induced by three doses of ketamine (different rows, as labelled). Grey line depicts mean locomotion speed in arbitrary units (see Fig. 1a
for actual units). Insets show cross-correlograms between normalised gamma power and locomotor activity. Right: Mean normalised gamma power in 1-
hour blocks, as labelled. *p,0.001 (repeated measures ANOVA) followed by Bonferroni post-hoc test. Data are shown as mean 6 SEM over animals.
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Figure 4 | Ketamine differently affects theta oscillations in different layers of the hippocampus. (a) Power spectral densities during 25-min of baseline
recordings (grey) and during 25-min after administration of 50 mg/kg ketamine IP (black) for three electrodes simultaneously recorded from a linear bundle
in a representative animal. (b) Group results of mean theta band (5–10 Hz) power recorded simultaneously in two subsets of 3 electrodes (inset) during a
5-min epoch of peak locomotion induced by ketamine, normalised by the mean theta power during baseline (dashed line); *p,0.001 (t-test). (c, d) Time-
course of mean theta (c) and delta (d) power in the two subsets of electrodes located in different hippocampal layers (see the inset in b for estimated electrode
locations). Grey and black arrows indicate saline and ketamine injections, respectively. Mean locomotor activity is also shown in grey (arbitrary units).
Notice that different y-axis scales are used for each subset of electrodes to facilitate comparison. Data are shown as mean 6 SEM over electrodes.
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black and white dots in the top left panel, respectively). CFC strength
for all time blocks is shown in the top right panel of each example.
These results are representative for recording sites with theta-HG
(Fig. 6a, c) and theta-HFO coupling (Fig. 6b, d) for the lowest (Fig. 6a,
b) and highest (Fig. 6c, d) ketamine dose. Surprisingly, we found that
ketamine had a differential effect on theta-HG coupling depending
on dose: while the lowest dose increased theta-HG coupling (Fig. 6a),
the highest dose disrupted this oscillatory interaction (Fig. 6c; see
also Fig. 7a for group results). On the other hand, ketamine increased
theta-HFO coupling at all doses (Fig. 6b, d and Fig. 7b).
Since CFC strength typically varies with theta power23,24,31, we next
investigated whether the results above could be related to ketamine
effect on theta oscillations. To that end, we plotted mean CFC
strength as a function of the theta/delta power ratio (Fig. 7a, b).
We note that due to the spectral leakage of delta power into the theta
rage that occurs during periods of immobility (c.f. section above), the
theta/delta ratio is a better measure of genuine theta activity in the
LFP than the mean power in the theta range. Moreover, the theta/
delta ratio is a spectral measure highly correlated with locomotion
speed (Supplementary Fig. S2 online), and thus also serves to invest-
igate whether changes in CFC strength are explained by changes in
locomotion. We found that ketamine altered CFC in a similar way as
described above even after controlling for this confounding factor
(see Fig. 7c for multiple regression analyses). These results therefore
show that acute NMDARblockade alters CFC in a frequency-specific
and dose-dependent way.
NMDAR blockade does not alter the distribution of electrical
dipoles in the hippocampus. Finally, we performed current source
density (CSD) analysis in one additional animal. Baseline CSD plots
(Fig. 8, top row) for the different frequency ranges were similar to
those previously described27,30. We found that ketamine did not alter
the spatial distribution of sinks and sources pairs (Fig. 8, bottom
row). These results indicate that NMDAR blockade alters pre-
existing hippocampal oscillations but does not generate new
dipoles. Further, these analyses indicate that the oscillations investi-
gated in this work are generated in the hippocampus, and not volume
conducted from other brain regions.
Discussion
In this study we showed that acute sub-anaesthetic doses of ketamine
alter the cross-frequency interaction between theta phase and the
amplitude of two higher frequency rhythms in the hippocampus:
high-gamma and HFO. In addition, we also found that ketamine
increases gamma and HFO power, alters oscillatory phase syn-
chrony, and differentially modulates theta power in a layer-specific
manner.
Consistent with previous studies12,14,15, we found altered behaviour
and increased hippocampal gamma power during acute blockade of
NMDAR. While low doses of ketamine cause correlated increases in
locomotor activity and total gamma power, higher doses can induce
different time-courses of behavioural and electrophysiological altera-
tions. In fact, ketamine also increases gamma oscillations in sedated
and anesthetised animals14. These observations indicate that altera-
tions in gamma power and hyperlocomotion are two independent
effects of NMDAR blockade. While hyperlocomotion induced by
acute NMDAR blockade is currently considered a predictive model
of positive schizophrenic symptoms16, the dissociation between
gamma activity and hyperlocomotion suggests that altered gamma
oscillations may have additional translational significance32.
Theta oscillations are believed to serve as a temporal organizer for
a variety of functions, such as sensorimotor integration33 and coor-
dination of cell assemblies by means of phase modulating gamma
oscillations2. Consistent with recent findings15, here we found that
acute NMDAR blockade differently alters theta power depending on
hippocampal layer. These findings show that different theta dipoles
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have different sensitivities to NMDAR blockade. Entorhinal cortex
inputs give rise to the theta dipole in stratum lacunosum-molecu-
lare34. A greater theta activity in this layer following NMDAR block-
ade may thus be associated with an overflow of sensory information
from the entorhinal cortex to the hippocampus.
Neuronal synchrony has been proposed to play a role in dynam-
ically selecting and routing information within and across brain
structures1. This hypothesis gave rise to the idea that abnormal syn-
chrony would underlie symptoms of cognitive disorders such as
autism and schizophrenia4. However, whether schizophrenia is
associated with increased or decreased neuronal synchrony remains
an open question5. Previous studies found reduced inter-trial phase
coherence (ITC) in schizophrenic patients6,35, typically accompany-
ing a decrease in stimulus-evoked gamma power35. It should be noted
that ITC measures the level of phase resetting following a sensory
stimulus within a recording site, and not the level of phase locking
between LFP oscillations recorded from different sites, as studied
here. Regarding the latter, positive schizophrenia symptoms may
be associated with increased connectivity7,36. Recent evidence sug-
gests that although schizophrenic patients have reduced evoked
gamma power, they could have abnormally high levels of basal
gamma power36,37. If confirmed, these findings would solve current
inconsistencies between animal models (which show increased levels
of gamma power and synchrony) and human studies (which point to
reduced evoked gamma power and synchrony; for discussion, see ref.
37). Altogether, our and other results suggest that psychotic symp-
toms caused by NMDAR hypofunction are associated with an over-
processing of information through functionally hyper-connected
structures. Therefore, like in other brain disorders such as
Parkinson disease and epilepsy4, pathological hypersynchrony could
also play a role in schizophrenia.
Theta-gamma coupling has been hypothesised to form a neural
coding system that allows the representation of multiple items in a
sequential order38. Abnormalities in theta-gamma coupling have been
thus suggested as a possible electrophysiological substrate of disor-
dered thoughts and impaired working memory8,38. Also, it should be
noted that recent CFC studies have demonstrated that theta modu-
lates multiple higher frequency bands, which occur within (30–
100 Hz) and beyond (.100 Hz) the traditional gamma band22–24,39.
For instance, theta preferentially modulates high-gamma (60–
100 Hz) in CA1 and low-gamma (30–60 Hz) in CA322,24,40.
Additionally, theta phase also modulates higher frequency activity
circumscribed into the 110–160 Hz band in stratum oriens-alveus23,39,
which we refer to as HFO. Interestingly, ketamine leads to a signifi-
cant increase in HFO activity in the nucleus accumbens28, a limbic
region implicated in schizophrenia that receives massive connections
from the hippocampus41. This suggests that higher frequency oscilla-
tions above the gamma range may also be altered in schizophrenia.
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Figure 6 | Ketamine alters cross-frequency coupling of neuronal oscillations. (a) Top left: time-course of theta-HG coupling strength and mean
locomotion speed (arbitrary units) before and after treatment with 25 mg/kg ketamine IP. Top right: Scatter plot of theta-HG coupling as a function of
theta/delta ratio for each 5-min time block (black: pre-ketamine; white: post-ketamine). Bottom: comodulation maps obtained from the 5-min epochs
indicated in the top left panel by black (pre-) and white (post-ketamine) circles. The results were obtained from an electrode in stratum lacunosum-
moleculare presenting prominent theta-HG coupling in a representative animal. (b) Same as in (a), but for an electrode in stratum oriens presenting
prominent theta-HFO coupling in the same animal. (c, d) Same as (a) and (b), but for an animal treated with 75 mg/kg ketamine IP. HG 5 high-gamma
(60–100 Hz), HFO 5 high-frequency oscillations (110–160 Hz), MI 5 modulation index.
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Here we showed that ketamine increases theta-HFO coupling
during peak locomotion at all doses studied, while its effect on
theta-gamma coupling was dose dependent. Importantly, none of
these effects can be explained by changes in theta power occurring
during hyperlocomotion. The cognitive implications of increased
theta-HFO coupling remain to be better understood, as well as the
functional role of HFO per se23,28,39. A recent study has shown that
physiological theta-HFO coupling significantly increases during
REM sleep31. REM sleep is a brain state associated with incongruous
thoughts and dreams. Many similarities have been pointed out
between REM sleep and psychosis42, leading some to suggest that
psychotic symptoms would be associated with intrusion of a dream-
ing state into an awake mind43,44. While these suggestions remain to
be appropriately tested, the finding of enhanced theta-HFO coupling
during REM sleep31 and following NMDAR blockade (present
results) supports such a view.
Theta-gamma coupling, on the other hand, increased with the
lowest dose of ketamine but was disrupted with the highest dose.
Current theories on the combined function of theta and gamma
oscillations suggest that disrupting their coupling would lead to def-
icits in brain functions such as working memory38. However, the
functional implications of increased theta-gamma coupling upon
lower levels of NMDAR blockade are harder to interpret. It may be
that increased oscillatory power, synchrony and cross-frequency
coupling are all correlates of an aberrant state of brain hyperexcit-
ability and altered information flow, which could underlie dysfunc-
tions such as hallucinations and flight of ideas.
Recent findings suggest that dysfunction of GABAergic interneur-
ons are likely to underlie the electrophysiological alterations reported
here45. Accordingly, ablation of NMDAR in parvalbumin (PV) pos-
itive interneurons in mice leads to enhancements of basal gamma
activity46,47.Moreover, ketamine does not induce hyperlocomotion in
these knockoutmice47, suggesting a critical involvement of the block-
ade of NMDAR in PV interneurons for the manifestation of positive
schizophrenic symptoms. NMDAR ablation in corticolimbic inter-
neurons has also been associated with the negative symptoms of the
disease48. These findings help link together the NMDAhypofunction
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hypothesis of schizophrenia with the alterations of GABAergic inter-
neurons seen in post-mortem studies of schizophrenic subjects49. In
addition to PV1 interneurons, hypofunction of NMDAR in oriens
lacunosum-moleculare (OLM) interneurons could also be involved
in the pathophysiology of schizophrenia50,51. These cells synapse on
distal portions of the apical dendrites of pyramidal cells, where pro-
jections from the entorhinal cortex arrive50. A hypofunction of OLM
cells would thus favour entorhinal cortex inputs52, which could then
lead to increased theta oscillations in stratum lacunosum-moleculare,
as observed here. GABAergic interneurons are also likely to underlie
coupling between theta and gamma rhythms50,53, and would thus
further mediate aberrant CFC patterns following NMDAR blockade.
In all, a preferential action of NMDA antagonists on inhibitory cells
is compatible with increased levels of excitation54,55 and altered neur-
onal oscillations.
Building a bridge between electrophysiological findings in animal
models and schizophrenic patients has proven to be a challenge5. A
large part of the alterations described here, particularly at the HFO
band, would not have been noticed by scalp EEG because of its
frequency band limitations. Data obtained by invasive techniques,
such as electrocorticograms, are unfortunately scarce in schizophre-
nia. In addition, antipsychotic drugs by themselves cause oscillatory
changes32, and are therefore important confounding factors in clin-
ical studies. Thus, while at variance with some previous human stud-
ies6,35, our results add to others7,36,37 in the suggestion that some
symptoms of the schizophrenia syndrome are mediated by an aber-
rant state of brain hyperactivity, including increases in the activity of
fast oscillations, phase synchrony and cross-frequency coupling.
Methods
Surgical implantation of electrodes. Animal care and surgery procedures were
approved by the Edmond and Lily Safra International Institute of Neuroscience of
Natal Committee for Ethics in Animal Experimentation (permit 02/2011). Eightmale
Wistar rats (2–3months old, 280–380 g) were used in the experiments. Seven animals
were chronically implanted in the left dorsal hippocampus with one electrode bundle
consisting of 8 vertically staggered tungstenmicrowires (50-mmdiameter). Electrodes
were aligned and spaced by 250 mm, spanning from CA1 stratum oriens-alveus to the
hilus of the dentate gyrus (deepest electrode in AP: 23.6 mm, ML: 22.5 mm, DV:
23.5 mm). One additional animal was implanted with a 16-site probe across the left
hippocampus (NeuroNexus Technologies; site area: 703 mm2; separation: 100 mm;
impedance: 1–1.5 MV; location: AP: 23.6 mm, ML: 22.5 mm). All recordings were
referenced to an epidural screw electrode implanted in the right parietal bone.
Experimental procedures.After recovering for 7–10 days, animals were individually
habituated to the recording room for 3 days. Experiments consisted of video and
electrophysiological recordings of freelymoving rats in a rectangular arena (503 43
40 cm) placed in a dimly lighted room. Recordings consisted of 3 stages: animals were
first allowed to explore the arena for one hour (basal); then were injected with saline
and recorded for another hour (saline); finally, animals received a single ketamine
injection (Ketamina AgenerH, 100 mg/ml, Agener Unia˜o, Embu-Guaçu, SP) of either
25 (n 5 6 rats), 50 (n 5 7 rats) or 75 mg/kg (n 5 5 rats) and were recorded for
additional three hours (ketamine). All injections were intraperitoneal (IP).
Depending on the stability of the recordings, each rat received up to 3 different doses
separated by at least 3 days.
It should be noted that ketamine effects vary widely across species56: while 1–4 mg/
kg of intravenous (IV) ketamine induces deep anaesthesia in humans, 20 mg/kg of IV
ketamine induces only hypnosis in rats57. Used in isolation, the reported anaesthetic
dose of ketamine in rats is 200 mg/kg IP55. Also, IP administration is far less effective
than subcutaneous (SC) injections15.
Electrophysiological recordings. Continuous recordings were performed using a
multi-channel acquisition processor (MAP, Plexon Inc). Local field potentials (LFPs)
were pre-amplified (10003), filtered (0.7–300 Hz), and digitised at 1000 Hz.
Electrode placement in CA1 was confirmed by inspecting coronal brain sections
stained with cresyl violet, and by assessing responses evoked by perforant path
stimulation (single pulse, 500 mA) along with other standard electrophysiological
parameters such as presence of ripple oscillations and multi-unit activity at the
pyramidal cell layer, theta phase reversal across stratum radiatum, andmaximal theta
power at the hippocampal fissure27.
Behavioural analysis.Animals were video-recorded at 30 frames/second. Tracking of
the animals position was made using MouseLabTracker (http://www.neuro.ufrn.br/
incerebro/mouselabtracker.php), an open-source MATLAB version of a previously
described software58. In order to avoid measuring small movements such as head and
tail movements only displacements $2.0 mm/frame were considered. Locomotor
activity was binned into 5-min blocks.
Data analysis. Analyses of electrophysiological data were performed in MATLAB
(MathWorks).
Filter settings and extraction of the instantaneous phase and amplitude. Filtering
was obtained using a linear finite impulse response filter by means of the eegfilt
function from the EEGLAB toolbox (http://sccn.ucsd.edu/eeglab/), which applies the
filter forward and then again backwards to ensure that phase delays are nullified. The
instantaneous amplitude and phase time series of a filtered signal were computed from
the analytical representation of the signal based on the Hilbert transform (hilbert
function, Signal Processing Toolbox).
Spectral analyses. Power spectra estimation was done by means of the Welch
periodogram method using the pwelch function from the Signal Processing Toolbox
(50%overlapping 4-sHammingwindows). Themean power over frequency ranges of
interest was calculated for each electrode individually, then averaged across electrodes
and animals. Phase coherence was calculated using the multitaper method by means
of the coherencysegc function from the Chronux toolbox59 (http://chronux.org/) with
parameters TW 5 3 and K 5 5 tapers, and window length of 4 seconds. Phase
coherence was averaged from all electrode pairs in all animals. Power and phase
coherence time-courses were obtained by averaging their values in 5-min blocks.
Estimation of phase-amplitude coupling and comodulation maps. To assess
phase-amplitude CFC, we used the Modulation Index (MI) recently described22,24.
This index measures coupling strength between two frequency ranges of interest: a
phase-modulating (fp) and an amplitude-modulated (fA) frequency. The
comodulation map is obtained by expressing the MI for several frequency band pairs
(4-Hz bin width with 2-Hz steps for fp, and 10-Hz bin width with 5-Hz steps for fA) in
a bi-dimensional pseudocolour plot (see Supplementary Fig. S3 online for an
illustrative example). Comodulation maps were computed using 5-min long LFPs
recorded from single electrodes; only time windows associated with robust theta
oscillations were used. Mean CFC strength between two frequency ranges was
obtained by averaging the corresponding MI values; for example, mean theta-HG
coupling corresponds to the average of MI values in the (4–10 Hz) 3 (60–100 Hz)
region of the comodulation map, and similarly for theta-HFO coupling. We only
computed theta-HG and theta-HFO coupling strength for electrodes that had theta-
HG and theta-HFO coupling in the comodulation map, respectively (see
Supplementary Fig. S4 online). Recording sites that did not present clear CFC in the
comodulation map, or which the comodulation map revealed spike
contamination30,60 (common in recordings from the CA1 pyramidal layer30 and
dentate gyrus23), were not taken into account in further analyses (see Supplementary
Fig. S4 online for representative examples of discarded electrodes). Consistent with
recent reports23,31, theta-HFO coupling was mainly present in electrodes in stratum
oriens-alveus , and theta-HG coupling from the CA1 pyramidal layer to stratum
lacunosum-moleculare/hippocampal fissure.
Triggered LFP averages and current source density (CSD). Probe signals were
amplified (2003), filtered (1 Hz–7.5 kHz), and digitised at 25 kHz (RHA2116, Intan
Technologies). LFP averages were obtained by first filtering the LFP signal into the
frequency ranges of interest; the amplitude peaks of each band were then identified
and used for averaging 500-ms epochs centred at these timestamps. CSD analysis was
obtained by -A12B-C for adjacent sites. We used 60-s periods of prominent theta
oscillations in these analyses.
Statistics. Group means were compared by t-test for independent samples or by
repeated measures ANOVA followed by Bonferroni post-hoc test. Multiple
regression was performed to study changes in CFC level corrected for changes in
locomotion and theta activity (as assessed by the theta/delta ratio; see Supplementary
Fig. S2 online).
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